DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) BCAX Holdings History
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s Bicara Therapeutics Inc Holding Summary
As of 2025-03-31, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) held - shares of Bicara Therapeutics Inc(BCAX), totaling N/A. This investment constitutes 0% of their stock portfolio, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) now holds 0% of the outstanding Bicara Therapeutics Inc(BCAX) stock.
The initial trade took place in 2024Q3. And since then DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) has made 1 purchases of BCAX, at an average price of $25.50, for a total of 1.80 Mil shares. In addition, there have been 1 sales at an average price of $13.28 for 1.80 Mil shares. Based on historical transaction data and BCAX's current price of $9.92, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s estimated gain on his BCAX holdings is $-21.94 Mil, reflecting a -47.92% gain to date.
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) BCAX ($9.92) Holding Chart
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) BCAX ($9.92) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
